Zeo ScientifiX Files 8-K with Financials and Exhibits

Ticker: ZEOX · Form: 8-K · Filed: Feb 18, 2025 · CIK: 1557376

Sentiment: neutral

Topics: 8-K, financial-statements, company-update

TL;DR

Zeo ScientifiX dropped an 8-K, check the financials and exhibits.

AI Summary

Zeo ScientifiX, Inc. filed an 8-K on February 18, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The company, formerly known as Organicell Regenerative Medicine, Inc., Biotech Products Services & Research, Inc., and BESPOKE TRICYCLES INC, is incorporated in Nevada and has its principal business address in Davie, Florida.

Why It Matters

This filing provides updated information and financial statements for Zeo ScientifiX, Inc., which is important for investors and stakeholders to assess the company's current status.

Risk Assessment

Risk Level: low — This is a routine filing of an 8-K, which typically reports on significant events or financial updates, and does not inherently indicate high risk.

Key Players & Entities

FAQ

What specific "Other Events" are being reported by Zeo ScientifiX, Inc. in this 8-K filing?

The filing indicates "Other Events" as an item information, but the specific details of these events are not provided in the excerpt.

What is the SIC code for Zeo ScientifiX, Inc. and what does it represent?

The SIC code is 2836, which represents "BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)".

When did Zeo ScientifiX, Inc. change its name from Organicell Regenerative Medicine, Inc.?

The date of the name change from Organicell Regenerative Medicine, Inc. was June 25, 2018.

What is the state of incorporation for Zeo ScientifiX, Inc.?

Zeo ScientifiX, Inc. is incorporated in Nevada.

What is the business phone number listed for Zeo ScientifiX, Inc.?

The business phone number listed is 888-963-7881.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on February 18, 2025 regarding Zeo ScientifiX, Inc. (ZEOX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing